Streetbeat News

Products Services

LIAN

LianBio has announced the results from its Phase 3 Explorer-CN trial of Mavacamten, which were presented at the European Society of Cardiology Congress and simultaneously published in JAMA Cardiology. The study confirms that the efficacy of Mavacamten can be extended to Chinese patients.

Portfolio Pulse from Happy Mohamed

August 28, 2023 | 8:06 pm

GLPG

Galapagos has announced the commencement of a Phase 2 study with its selective TYK2 inhibitor, GLPG3667, in patients with active systemic lupus erythematosus.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 8:01 pm

GEOS

Geospace Technologies has launched Aquanaut, a low frequency ocean bottom node. This new product is expected to enhance the company's offerings in the ocean bottom seismic data acquisition market.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 8:01 pm

DASH

UBER

Uber Eats is planning to introduce an AI-powered chatbot to help users decide their next meal, according to a Bloomberg report. The AI Assistant is designed to help users find relevant restaurant dishes. Uber's CEO, Dara Khosrowshahi, had previously mentioned the company's work on an AI chatbot. Competitors like DoorDash and Instacart are also integrating AI tools into their apps. Uber Eats accounts for nearly one-third of Uber's revenue.

Portfolio Pulse from Aaron Bry

August 28, 2023 | 7:13 pm

AGIL

GDC

HE

HT

IDEX

NVCR

U.S. stocks traded higher with the Dow Jones gaining over 100 points. Real estate shares jumped by 0.9%. Hawaiian Electric Industries, Inc. (NYSE:HE) shares shot up 40% after the company responded to a lawsuit filed by the County of Maui. GD Culture Group Limited (NASDAQ:GDC) shares rose 43% after announcing the launch of a live-streaming e-commerce business on TikTok. Hersha Hospitality Trust (NYSE:HT) shares gained 56% after announcing a merger with KSL Capital Partners LLC. AgileThought, Inc. (NASDAQ:AGIL) shares dropped 33% after being downgraded from Buy to Sell. NovoCure Limited (NASDAQ:NVCR) shares were down 36% after its Phase 3 trial did not meet its primary endpoint. Ideanomics, Inc. (NASDAQ:IDEX) shares fell 18% after reporting Q2 results.

Portfolio Pulse from Lisa Levin

August 28, 2023 | 7:00 pm

AMCX

WBD

Warner Bros. Discovery's streaming platform Max will feature over 200 episodes of recent AMC Networks content from September 1 to October 31. This move is part of media companies' efforts to bolster their streaming platforms and attract more viewers. The AMC shows on Max will be available to both ad-supported and commercial-free subscribers at no additional cost. This partnership will also allow consumers to view AMC programming, which is prominently featured on its own service, AMC+.

Portfolio Pulse from Happy Mohamed

August 28, 2023 | 6:34 pm

TSLA

Elon Musk, CEO of Tesla Inc (NASDAQ:TSLA), has indicated that Full Self-Driving (FSD) integration on new Tesla vehicles equipped with Hardware 4 (HW4) will take at least another six months. The company's primary focus is currently on refining FSD for vehicles with Hardware 3 (HW3). Tesla's Model S, Model X, and Model Y have included HW4 since March and May 2023 respectively, while Model 3 still comes with HW3. Tesla owners can access FSD by paying a one-time fee of $15,000 or a subscription of $200 per month.

Portfolio Pulse from Benzinga EV Insights

August 28, 2023 | 6:18 pm

DASH

UBER

DoorDash, Inc (NYSE:DASH) is introducing AI-driven voice ordering to its platform to optimize restaurant support and boost sales. This comes after Uber Technologies, Inc (NYSE:UBER) integrated AI into the voice-ordering feature of Uber Eats. DoorDash currently holds 65% of food-delivery sales in the U.S.

Portfolio Pulse from Anusuya Lahiri

August 28, 2023 | 6:18 pm

NVO

The Danish Health Ministry has suggested that reimbursing Novo Nordisk's weight-loss drug, Wegovy, could cost the state up to $4 billion annually. Wegovy is a popular medication for weight loss and also shows cardiovascular benefits. The calculation is based on the cost of Wegovy for approximately 900,000 Danes with a Body Mass Index surpassing 30. The increasing costs of healthcare and the advent of new medications like Wegovy highlight the financial challenges public healthcare systems face.

Portfolio Pulse from Vandana Singh

August 28, 2023 | 6:18 pm

ESPR

Esperion Therapeutics Inc (NASDAQ:ESPR) announced positive results from two CLEAR Outcomes Study Late-Breakers at the European Society of Cardiology Congress 2023. The studies showed that bempedoic acid, a drug used to lower LDL-C, reduced the risk of major adverse cardiovascular events by up to 31%. The drug also demonstrated benefits in patients with diabetes and did not increase rates of new-onset diabetes. Following the announcement, ESPR shares rose by 15.90%.

Portfolio Pulse from Vandana Singh

August 28, 2023 | 6:10 pm